Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

sector : Process industries    tags : Cancer    save search

Cancer Registry Software Market size to grow by USD 82.3 million from 2022-2027, North America to account for 51% of market growth, Technavio
Published: 2024-03-01 (Crawled : 16:00) - prnewswire.com
AMCR | $8.98 -0.55% 0.0% 5.6M twitter stocktwits trandingview |
Process Industries
| | O: -0.11% H: 0.66% C: 0.44%

america million software cancer registry market
Valvoline Instant Oil Change Locations Raise Funds for the Fight Against Cancer
Published: 2023-10-19 (Crawled : 15:00) - globenewswire.com
VVV | $42.23 0.96% 0.0% 770K twitter stocktwits trandingview |
Process Industries
| | O: -0.41% H: 0.98% C: -1.68%

change cancer oil
Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment
Published: 2023-10-16 (Crawled : 11:00) - globenewswire.com
TLRY | $1.84 6.98% 6.52% 25M twitter stocktwits trandingview |
Process Industries
| | O: 0.0% H: 1.99% C: 1.0%

cannabis cancer treatment medical trial glioblastoma tilray study
Valvoline Instant Oil Change Locations Raise Funds for the Fight Against Cancer
Published: 2023-09-28 (Crawled : 16:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| | O: 0.22% H: 0.0% C: 0.0%
VVV | $42.23 0.96% 0.0% 770K twitter stocktwits trandingview |
Process Industries
| | O: 0.03% H: 0.87% C: 0.19%

change cancer oil
The Biosurfactants Market to grow at a CAGR of 5.6% from 2022 to 2027; The potential use of biosurfactants in cancer treatment is a major trend - Technavio
Published: 2023-08-10 (Crawled : 07:00) - prnewswire.com
IOSP | $123.08 1.17% 1.15% 58K twitter stocktwits trandingview |
Process Industries
| | O: 0.62% H: 2.08% C: 1.84%

cancer treatment potential market
Valvoline Instant Oil ChangeSM supports cancer research and patient care at Dana-Farber Cancer Institute
Published: 2023-08-01 (Crawled : 13:20) - globenewswire.com
VVV | $42.23 0.96% 0.0% 770K twitter stocktwits trandingview |
Process Industries
| | O: -0.24% H: 0.87% C: -1.0%

institute cancer care research
Citrus Consumption And Breast Cancer Risk
Published: 2023-04-29 (Crawled : 04:20) - limoneira.com
LMNR 4 | $19.68 -0.15% -0.15% 33K twitter stocktwits trandingview |
Process Industries
| Email alert Add to watchlist
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

breast citrus cancer risk
4Front Ventures and Pink Gene Foundation Launch National Breast Cancer Awareness Month Campaign
Published: 2022-09-29 (Crawled : 14:00) - 4frontventures.com
FFNTF | $0.0968 0.0% 22K twitter stocktwits trandingview |
Process Industries
| | O: -3.65% H: 2.84% C: 2.27%

breast cancer
The Scent Of Lemons May Help Treat Cancer
Published: 2022-09-23 (Crawled : 21:00) - limoneira.com
LMNR 4 | $19.68 -0.15% -0.15% 33K twitter stocktwits trandingview |
Process Industries
| Email alert Add to watchlist
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

cancer
Study: Lemon-Derived Elements In Cancer Treatment
Published: 2022-09-02 (Crawled : 01:00) - limoneira.com
LMNR 4 | $19.68 -0.15% -0.15% 33K twitter stocktwits trandingview |
Process Industries
| | O: 1.4% H: 0.0% C: -5.35%

treatment cancer
BioSpace Movers & Shakers: National Cancer Institute, Evelo, Eagle, ROME & More
Published: 2022-07-22 (Crawled : 14:00) - biospace.com/
CDXS | $2.895 1.22% 1.21% 190K twitter stocktwits trandingview |
Process Industries
| | O: -0.37% H: 0.03% C: -7.56%

cancer
Lemon & Ginger: New Study Shows Anti-Cancer Results
Published: 2022-05-27 (Crawled : 19:00) - limoneira.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist
LMNR 4 | $19.68 -0.15% -0.15% 33K twitter stocktwits trandingview |
Process Industries
| Email alert Add to watchlist

results cancer
ImmunityBio Announces Completion of $470 Million Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of COVID T-Cell Universal Boost Vaccine Trial and Provides Update on Bladder Cancer BLA Filing
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
IBRX | $5.48 10.93% 9.85% 31M twitter stocktwits trandingview |
Manufacturing
| | O: 1.53% H: 1.2% C: -2.41%
AMRS | $0.05 -21.88% -16.36% 47M twitter stocktwits trandingview |
Process Industries
| | O: -2.79% H: 1.93% C: -3.72%

als bladder cancer trials trial covid cel clinical trials cancer vaccine phase 3 merge t-cell bladder
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.